A 4-year-old girl is brought to the emergency department 1 hour after accidental ingestion of her mother's organophosphate pesticide (used in the garden). On examination, she is conscious but distressed, with excessive salivation, bronchospasm (wheeze on auscultation), miosis (pupils 2 mm), and muscle fasciculations visible over the thighs. Heart rate is 52/min, blood pressure 88/54 mmHg, and respiratory rate 28/min with SpO₂ 85% on room air. Serum cholinesterase level is 35% of normal. What is the most appropriate immediate pharmacological intervention?

Explanation

## Clinical Diagnosis: Organophosphate Poisoning The clinical presentation is diagnostic of acute organophosphate (OP) toxicity: ### Classic Cholinergic Crisis Features (Mnemonic: SLUDGE + Muscle Signs) **Key Point:** SLUDGE = **S**alivation, **L**acrimation, **U**rination, **D**efecation, **G**astrointestinal upset, **E**mesis. Additional signs: - **Miosis** (pinpoint pupils) — muscarinic effect - **Bronchospasm + bradycardia** — parasympathomimetic crisis - **Muscle fasciculations** — nicotinic effect (acetylcholine excess at neuromuscular junction) - **Reduced cholinesterase** (35% of normal) — confirms OP inhibition ## Pathophysiology Organophosphates irreversibly inhibit acetylcholinesterase (AChE), leading to: 1. Accumulation of acetylcholine at synapses and neuromuscular junctions 2. Unopposed parasympathomimetic (muscarinic + nicotinic) effects 3. Respiratory failure (bronchospasm + respiratory muscle paralysis) ## Two-Drug Antidote Strategy | Drug | Mechanism | Timing | Dose (Pediatric) | |------|-----------|--------|------------------| | **Atropine** | Muscarinic antagonist | Immediate | 0.05 mg/kg IV bolus; repeat q5–10 min | | **Pralidoxime (2-PAM)** | Oxime; reactivates AChE (if given early) | Within 24–48 hrs of exposure | 25 mg/kg IV over 5–10 min | ### Why Both Drugs Are Essential **Atropine:** - Blocks **muscarinic** effects (salivation, bronchospasm, bradycardia, miosis) - Does NOT reverse **nicotinic** effects (muscle fasciculations, weakness, paralysis) - Must be given immediately to prevent respiratory failure **Pralidoxime (2-PAM):** - Reactivates acetylcholinesterase by removing the phosphoryl group from the enzyme - Effective only if given within 24–48 hours of exposure (before "aging" of the enzyme-inhibitor complex) - Reverses **both muscarinic and nicotinic** effects - Must be given **after** atropine (atropine alone may cause initial worsening of nicotinic signs) **Clinical Pearl:** The combination of atropine + pralidoxime is synergistic. Atropine buys time by controlling life-threatening muscarinic effects (bronchospasm, bradycardia), while pralidoxime addresses the root cause (enzyme reactivation). **High-Yield:** OP poisoning is one of the few pediatric emergencies where two specific antidotes must be given together in a defined sequence. Pralidoxime alone is ineffective for muscarinic crisis; atropine alone does not reverse nicotinic paralysis. ## Immediate Management Algorithm ```mermaid flowchart TD A[Organophosphate Poisoning Suspected]:::outcome --> B[Secure Airway + O₂]:::action B --> C[Atropine 0.05 mg/kg IV]:::action C --> D{Muscarinic Signs Resolved?}:::decision D -->|No| E[Repeat Atropine q5-10 min]:::action E --> D D -->|Yes| F[Pralidoxime 25 mg/kg IV over 5-10 min]:::action F --> G[Continuous Monitoring + Repeat Doses]:::action G --> H[Supportive Care: Ventilation if Needed]:::action ``` ## Dosing & Monitoring - **Atropine:** Start 0.05 mg/kg IV; repeat every 5–10 minutes until signs of atropinization (dry mouth, dilated pupils, increased heart rate) or resolution of bronchospasm - **Pralidoxime:** 25 mg/kg IV infusion over 5–10 minutes; may repeat every 1–2 hours if needed - **Supportive care:** Mechanical ventilation if respiratory failure despite antidotes [cite:Park 26e Ch 10; Harrison 21e Ch 448]